You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Sale Disclosure
Farzan Nima · SEC Form 4 · Filed Jun 8, 2026
Sale
Calculated transaction value
$28.17K
Farzan Nima Director
KROS
Keros Therapeutics
KROS
Transaction date
Jun 4, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 4 days later
KROS daily price context
Close on/before transaction
$10.77
Jun 4, 2026
First close after public filing
$10.07
Jun 9, 2026
30-day return after filing
+15.89%
Through Jul 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,625 shares @ $10.73
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001808296-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$28.17K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Sale | Jun 4, 2026 | $28.17K |